SEC Form 4 · accession 0001624048-15-000004
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James T. Ogle
Director
Period of report
Jun 5, 2015
Accepted (ET)
Jun 9, 2015 · 8:28 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Jun 5, 2015 | A | 1,700 | $0.00 | A | 238,386 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F2 | $37.38 | Jun 5, 2015 | A | 3,401 | A | — | Jun 5, 2025 | Class A Common Stock | 3,401 | 3,401 | D |
Explanation of responses
- F1Represents an award of restricted stock units which vests in three equal annual installments of 33 1/3% beginning on June 5, 2016, subject to continued service on the Issuer's Board of Directors.
- F2The shares subject to this option vest in three equal annual installments of 33 1/3% beginning on June 5, 2016, subject to continued service on the Issuer's Board of Directors.
Remarks
The director received the annual grant of $100,000 plus an additional $27,123 to cover the period from the originally planned grant date to the date of the annual meeting in order to synchronize all non-employee director annual grants to be the date of the annual meeting.